SBUX:NASDAQStarbucks Corporation Analysis
Data as of 2026-03-09 - not real-time
$99.77
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Starbucks is trading in a clear bullish technical environment – the price sits above the short‑term and long‑term moving averages, the MACD line is above its signal, and the RSI remains in the upper‑mid range, suggesting continued upward momentum. Support around the mid‑90s is holding firm while the stock approaches a key resistance near the high‑100s, and volume has remained stable, reinforcing the bullish bias. However, the recent announcement of new global tariffs introduced a short‑term headwind, prompting a noticeable intraday dip and adding regulatory uncertainty to the mix. Market sentiment is currently at an "Extreme Greed" level, indicating strong investor enthusiasm despite the policy risk. Fundamentally, the valuation appears stretched – the trailing P/E is exceptionally high and the discounted cash‑flow fair value is far below the current market price, while the price‑to‑book ratio is negative, reflecting a balance sheet that is not supporting the price. The dividend payout ratio exceeds 200%, raising concerns about the sustainability of the 2.5% yield. Nonetheless, the company's "Back to Starbucks" turnaround plan is showing early signs of traction, and its brand strength and global footprint remain solid. Analysts are split, with a median price target near the current level and a mix of neutral to buy recommendations, highlighting the tension between growth prospects and valuation concerns. Overall, the stock is positioned in a bullish technical setup but faces significant valuation and macro‑policy challenges.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators with price above key moving averages
- Recent price dip creates a potential entry point
- Tariff uncertainty adds short‑term caution
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Turnaround initiatives beginning to show results
- Valuation remains significantly above intrinsic estimates
- Mixed analyst sentiment with neutral to buy ratings
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong brand and global presence support sustainable growth
- High valuation and unsustainable dividend payout limit upside
- Long‑term exposure to consumer cyclical dynamics and regulatory changes
Key Metrics & Analysis
Financial Health
Revenue Growth5.50%
Profit Margin3.63%
P/E Ratio83.1
ROA6.87%
P/B Ratio-13.5
Op. Cash Flow$4.3B
Free Cash Flow$-1439387520
Technical Analysis
TrendBullish
RSI61.7
Support$93.55
Resistance$101.20
MA 20$97.20
MA 50$93.68
MA 200$89.01
MACDBullish
VolumeStable
Fear & Greed Index75.89
Valuation
Fair Value$26.79
Target Price$100.06
Upside/Downside0.30%
GradeOvervalued
TypeGrowth
Dividend Yield2.51%
Risk Assessment
Beta1.05
Volatility27.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.